Literature DB >> 9395378

Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection.

L Weiss1, A Si-Mohamed, P Giral, P Castiel, A Ledur, C Blondin, M D Kazatchkine, N Haeffner-Cavaillon.   

Abstract

Plasma levels of proinflammatory cytokines, cytokine inhibitors, and the beta chemokines RANTES, macrophage inhibitory protein (MIP)-1alpha, and monocyte chemoattractant protein (MCP)-1 were studied in relationship with virus load in 40 patients exhibiting plasma levels of HIV RNA ranging between undetectable and levels >10(6) copies/mL. Mean plasma levels of MCP-1 were increased in patients with high virus load compared with HIV-seropositive subjects with undetectable plasma viral RNA and healthy controls. MCP-1 levels were directly correlated with plasma levels of HIV RNA. No correlation was observed between virus load and plasma concentrations of MIP-1alpha and RANTES. The results suggest that low rates of viral replication in vivo are not dependent on increased production of the suppressive chemokines RANTES and MIP-1alpha. Since MCP-1 upregulates viral replication in vitro, the results may suggest a role for MCP-1 in triggering viral replication in HIV disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395378     DOI: 10.1086/517341

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.

Authors:  A Garzino-Demo; R B Moss; J B Margolick; F Cleghorn; A Sill; W A Blattner; F Cocchi; D J Carlo; A L DeVico; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.

Authors:  F Cocchi; A L DeVico; R Yarchoan; R Redfield; F Cleghorn; W A Blattner; A Garzino-Demo; S Colombini-Hatch; D Margolis; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 3.  Chemokine receptors and chemokines in HIV infection.

Authors:  A Garzino-Demo; A L DeVico; R C Gallo
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

4.  CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release.

Authors:  David O Ajasin; Vasudev R Rao; Xuhong Wu; Santhamani Ramasamy; Mario Pujato; Arthur P Ruiz; Andras Fiser; Anne R Bresnick; Ganjam V Kalpana; Vinayaka R Prasad
Journal:  Elife       Date:  2019-06-07       Impact factor: 8.140

5.  Chemokine responses are increased in HIV-infected Malawian children with invasive pneumococcal disease.

Authors:  Enitan D Carrol; Limangeni A Mankhambo; Paul Balmer; Standwell Nkhoma; Daniel L Banda; Malcolm Guiver; Graham Jeffers; Nick Makwana; Elizabeth M Molyneux; Malcolm E Molyneux; Rosalind L Smyth; C Anthony Hart
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-01       Impact factor: 3.731

Review 6.  HIV infection and pathogenesis: what about chemokines?

Authors:  R C Gallo; A Garzino-Demo; A L DeVico
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

7.  Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.

Authors:  S Zanussi; C Simonelli; M T Bortolin; M D'Andrea; C Crepaldi; E Vaccher; G Nasti; D Politi; L Barzan; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

8.  Plasma cytokine levels are related to brain volumes in HIV-infected individuals.

Authors:  Assawin Gongvatana; Stephen Correia; Shira Dunsiger; Lynne Gauthier; Kathryn N Devlin; Skye Ross; Bradford Navia; Karen T Tashima; Suzanne DeLaMonte; Ronald A Cohen
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-02       Impact factor: 4.147

Review 9.  Monocyte chemoattractant protein-1 (MCP-1): an overview.

Authors:  Satish L Deshmane; Sergey Kremlev; Shohreh Amini; Bassel E Sawaya
Journal:  J Interferon Cytokine Res       Date:  2009-06       Impact factor: 2.607

10.  The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.

Authors:  Hemant Kulkarni; Vincent C Marconi; Weijing He; Michael L Landrum; Jason F Okulicz; Judith Delmar; Dickran Kazandjian; John Castiblanco; Seema S Ahuja; Edwina J Wright; Robin A Weiss; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  Blood       Date:  2009-07-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.